Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EX-DKD: Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease
jRCTs061190027Completed
- Sponsor
- Not applicable
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in diabetic glomerulosclerosis, hypertension (HTN) and type 2 diabetes mellitus (T2DM), sponsored by Not applicable. Primary endpoint: Change from baseline in home early-morning sitting systolic and diastolic blood pressure. Started Feb 2020; status: completed.
02
Drugs
esaxerenone
03
Conditions
diabetic glomerulosclerosishypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs061190027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061190027.